Patents by Inventor Lindsay DEVORKIN

Lindsay DEVORKIN has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • CD3 T-Cell Engagers and Methods of Use
    Publication number: 20230295310
    Abstract: Anti-CD3 antibodies for use in the diagnosis or treatment of hyperproliferative or autoimmune disorders methods of using the same for detecting and/or treating a hyperproliferative or autoimmune disorders.
    Type: Application
    Filed: March 20, 2023
    Publication date: September 21, 2023
    Applicant: AbCellera Biologics Inc.
    Inventors: Lindsay DEVORKIN, Aaron Paul YAMNIUK, Bryan Crawford BARNHART, Wei WEI, Kevin HEYRIES, Harveer DHUPAR, Sherie DUNCAN, Timothy M. JACOBS
  • COMPOSITIONS AND METHODS FOR ENHANCED LYMPHOCYTE-MEDIATED IMMUNOTHERAPY
    Publication number: 20220133793
    Abstract: Lymphocytes having a suppressed autophagy gene useful in immunotherapy are disclosed. The lymphocytes can express an antigen targeting receptor such as a chimeric antigen receptor (CAR) or endogenous or engineered T-cell receptor to target cells expressing a tumor-specific antigen. Methods of making and using such lymphocytes are disclosed. Some such lymphocytes are useful in conducting CAR-T or TCR-T therapy.
    Type: Application
    Filed: February 12, 2020
    Publication date: May 5, 2022
    Inventors: Julian J. LUM, Lindsay DEVORKIN, Yannick DOYON, Gillian CARLETON